Corbus Pharmaceuticals Holdings, Inc. Stock
Stocks
CRBP
US21833P3010
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.17 USD | +4.41% |
|
+13.38% | +24.94% |
| Market Cap | 197M 170M 159M 146M 274M 18.72B 279M 1.86B 732M 9.38B 739M 722M 31.02B | P/E 2026 * |
-1.86x | P/E 2027 * | -1.78x |
|---|---|---|---|---|---|
| Enterprise Value | 197M 170M 159M 146M 274M 18.72B 279M 1.86B 732M 9.38B 739M 722M 31.02B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 861x |
| Free-Float |
94.76% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Corbus Pharmaceuticals Holdings, Inc.
| 1 day | +4.41% | ||
| 1 week | +13.38% | ||
| Current month | +13.38% | ||
| 1 month | +6.49% | ||
| 3 months | -7.21% | ||
| 6 months | +29.89% | ||
| Current year | +24.94% |
| 1 week | 8.71 |  | 10.23 |
| 1 month | 8.5 | | 10.23 |
| Current year | 7.12 | | 12.88 |
| 1 year | 7.12 | | 20.56 |
| 3 years | 3.03 | | 61.9 |
| 5 years | 2.11 | | 61.9 |
| 10 years | 2.11 | | 323.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yuval Cohen
CEO | Chief Executive Officer | 51 | 11/04/2014 |
Sean Moran
DFI | Director of Finance/CFO | 68 | 11/04/2014 |
Leonardo Nicacio
CTO | Chief Tech/Sci/R&D Officer | 48 | 06/07/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Yuval Cohen
BRD | Director/Board Member | 51 | 11/04/2014 |
John Jenkins
BRD | Director/Board Member | 68 | 05/06/2018 |
Rachelle Jacques
CHM | Chairman | 54 | 15/05/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/05/26 | Free | Director | 16,100 | 0.0908% | ||
| 19/05/26 | Free | Director | 32,200 | 0.1815% | ||
| 17/02/26 | Sell | Chief Operating Officer | 847 | 0.0048% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.41% | +13.38% | +20.64% | +57.92% | 197M | |
| +8.49% | +20.55% | +70.77% | +110.32% | 68.12B | |
| +1.25% | +2.44% | +34.27% | +70.43% | 55.18B | |
| -1.09% | +32.96% | +19.67% | +494.56% | 28.63B | |
| +10.83% | +18.38% | +56.20% | +6.03% | 23.99B | |
| +2.72% | +3.41% | -16.11% | -7.96% | 23.53B | |
| +6.50% | +7.56% | +44.65% | -21.73% | 18.45B | |
| +6.20% | +11.51% | +33.87% | +693.38% | 16.44B | |
| -3.88% | +16.98% | +199.30% | +359.77% | 15.83B | |
| +3.58% | +1.96% | +43.35% | +163.76% | 13.4B | |
| Average | +3.90% | +11.85% | +50.66% | +192.65% | 26.38B | |
| Weighted average by Cap. | +4.36% | +13.10% | +50.67% | +168.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 229K 198K 185K 169K 319K 21.75M 324K 2.17M 850K 10.9M 858K 840K 36.05M |
| Net income | -115M -99.43M -92.85M -85.18M -160M -10.94B -163M -1.09B -428M -5.48B -432M -422M -18.13B | -129M -111M -104M -95.39M -179M -12.25B -182M -1.22B -479M -6.14B -483M -473M -20.3B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | $10.17 | +4.41% | 357,127 |
| 06/08/26 | $9.740 | +1.78% | 157,996 |
| 05/08/26 | $9.570 | +1.81% | 235,973 |
| 04/08/26 | $9.400 | +5.38% | 264,968 |
| 03/08/26 | $8.920 | -0.56% | 131,977 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRBP Stock
Select your edition
All financial news and data tailored to specific country editions
